Your browser is no longer supported. Please, upgrade your browser.
Settings
ENZ Enzo Biochem, Inc. daily Stock Chart
ENZ [NYSE]
Enzo Biochem, Inc.
Index- P/E66.88 EPS (ttm)0.06 Insider Own6.10% Shs Outstand48.26M Perf Week21.59%
Market Cap206.55M Forward P/E- EPS next Y-0.39 Insider Trans4.11% Shs Float44.04M Perf Month16.62%
Income3.20M PEG- EPS next Q-0.14 Inst Own71.00% Short Float2.98% Perf Quarter67.84%
Sales84.70M P/S2.44 EPS this Y-306.80% Inst Trans1.21% Short Ratio5.66 Perf Half Y43.62%
Book/sh1.92 P/B2.23 EPS next Y- ROA2.10% Target Price5.00 Perf Year-26.84%
Cash/sh1.33 P/C3.22 EPS next 5Y- ROE2.70% 52W Range2.32 - 5.83 Perf YTD53.96%
Dividend- P/FCF- EPS past 5Y13.80% ROI-13.50% 52W High-26.59% Beta1.48
Dividend %- Quick Ratio5.10 Sales past 5Y2.20% Gross Margin31.40% 52W Low84.48% ATR0.24
Employees460 Current Ratio5.60 Sales Q/Q-21.80% Oper. Margin2.10% RSI (14)68.89 Volatility9.71% 6.56%
OptionableYes Debt/Eq0.00 EPS Q/Q830.70% Profit Margin2.50% Rel Volume2.08 Prev Close4.07
ShortableYes LT Debt/Eq0.05 EarningsJun 10 AMC Payout0.00% Avg Volume232.19K Price4.28
Recom- SMA2022.30% SMA5022.05% SMA20023.51% Volume482,372 Change5.16%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Jun-11-19 02:54PM  What Kind Of Share Price Volatility Should You Expect For Enzo Biochem, Inc. (NYSE:ENZ)? Simply Wall St. +13.07%
06:30AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Jun-10-19 04:17PM  Enzo Biochem Reports Fiscal Third Quarter and Nine Months Operating Results Business Wire
Jun-05-19 09:00AM  Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2019 Results Tuesday, June 11, 2019 at 8:30 AM E.T. Business Wire
May-10-19 10:48AM  Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod Business Wire
May-02-19 06:00AM  Biotech Bets and a Goodbye from a Favorite Expert MoneyShow
Apr-23-19 02:19PM  What Percentage Of Enzo Biochem, Inc. (NYSE:ENZ) Shares Do Insiders Own? Simply Wall St.
Apr-01-19 06:25PM  Edited Transcript of ENZ earnings conference call or presentation 12-Mar-19 12:30pm GMT Thomson Reuters StreetEvents
Mar-11-19 04:50PM  Enzo Biochem: Fiscal 2Q Earnings Snapshot Associated Press
04:10PM  Enzo Biochem Reports Second Fiscal Quarter and First Half 2019 Results and Reports Progress on Its Investments and Strategic Goals Business Wire
Mar-05-19 04:05PM  Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2019 Results Tuesday, March 12, 2019 at 8:30 AM E.T. Business Wire
Feb-26-19 12:45PM  Why Enzo Biochem, Inc.s (NYSE:ENZ) CEO Pay Matters To You Simply Wall St.
Jan-29-19 07:35AM  Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem New Research Emphasizes Economic Growth GlobeNewswire
Jan-06-19 11:36PM  Edited Transcript of ENZ earnings conference call or presentation 11-Dec-18 1:30pm GMT Thomson Reuters StreetEvents
Jan-02-19 01:40PM  How Many Insiders Bought Enzo Biochem, Inc. (NYSE:ENZ) Shares? Simply Wall St.
Dec-10-18 04:21PM  Enzo Biochem: Fiscal 1Q Earnings Snapshot Associated Press
04:15PM  Enzo Biochem Reports Fiscal 2019 First Quarter Results Business Wire
Dec-06-18 09:00AM  Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T. Business Wire +9.73%
Dec-03-18 09:00AM  Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer Business Wire
Nov-14-18 12:57PM  What Kind Of Shareholder Owns Most Enzo Biochem Inc (NYSE:ENZ) Stock? Simply Wall St.
Oct-29-18 08:25AM  Market Trends Toward New Normal in Polaris Industries, NIKE, Charles River Laboratories International, Actuant, Caesarstone, and Enzo Biochem Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-17-18 08:15AM  The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise Benzinga
Oct-16-18 09:42PM  Edited Transcript of ENZ earnings conference call or presentation 16-Oct-18 12:30pm GMT Thomson Reuters StreetEvents -5.33%
08:52AM  The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist Benzinga
06:30AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Oct-15-18 04:20PM  Enzo Biochem: Fiscal 4Q Earnings Snapshot Associated Press
04:05PM  Enzo Biochem Reports Fourth Quarter and Fiscal 2018 Results Business Wire
Oct-11-18 12:49PM  Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T. Business Wire
Oct-03-18 07:33PM  Top 5 Biotech Stocks for 2018 Investopedia +7.14%
Aug-27-18 08:30AM  Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy Business Wire
Aug-02-18 08:15AM  Market Trends Toward New Normal in Sandy Spring, Tupperware Brands, Dolby Laboratories, AeroVironment, Barnes Group, and Enzo Biochem Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-18-18 09:00AM  Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Womens Health Area Business Wire
Jul-06-18 07:10AM  Blog Exposure - Bruker Buys Dutch Milk Analysis Equipment Manufacturer Lactotronic to Expand its Presence in the Dairy Industry ACCESSWIRE
Jun-13-18 06:03AM  Edited Transcript of ENZ earnings conference call or presentation 12-Jun-18 12:30pm GMT Thomson Reuters StreetEvents
Jun-12-18 08:47AM  Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate Benzinga -8.96%
Jun-11-18 04:21PM  Enzo Biochem: Fiscal 3Q Earnings Snapshot Associated Press
04:10PM  Enzo Biochem Reports Third Quarter Results Business Wire
Jun-06-18 10:00AM  Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T. Business Wire
Apr-24-18 10:00AM  Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case Business Wire
Mar-14-18 03:58AM  Edited Transcript of ENZ earnings conference call or presentation 13-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
Mar-13-18 08:04AM  Earnings Outlook For Enzo Biochem Benzinga -6.82%
06:45AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Mar-12-18 04:29PM  Enzo Biochem reports 2Q loss Associated Press
04:05PM  Enzo Biochem Reports Second Quarter and First Half Results Business Wire
Mar-08-18 04:10PM  Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T. Business Wire
Feb-26-18 07:30AM  Exploring Fundamental Drivers Behind Enzo Biochem, RPX, The Hackett Group, 2U, AK Steel Holding, and Och-Ziff Capital Management Group New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-22-18 09:00AM  Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test Business Wire
Jan-09-18 07:00AM  Free Post Earnings Research Report: Enzo Biochems Revenue Grew 5%; Net Loss Narrowed ACCESSWIRE
Dec-19-17 07:50AM  Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Dec-13-17 07:00AM  Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas ACCESSWIRE
Dec-11-17 04:53PM  Edited Transcript of ENZ earnings conference call or presentation 8-Dec-17 1:30pm GMT Thomson Reuters StreetEvents
02:46PM  Enzo Biochem (ENZ) Q1 2018 Earnings Conference Call Transcript Motley Fool
10:40AM  Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q1, 2018 By the Numbers : December 11, 2017 Capital Cube
Dec-08-17 07:00AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE -7.57%
Dec-07-17 04:15PM  Enzo Biochem reports 1Q loss Associated Press
04:10PM  Enzo Biochem Reports Improved First Quarter Results Business Wire
01:39PM  ETFs with exposure to Enzo Biochem, Inc. : December 7, 2017 Capital Cube
Dec-05-17 08:00AM  Enzo Biochem Schedules Teleconference to Discuss First Quarter 2018 Results Friday, December 8, 2017 at 8:30 AM E.T. Business Wire
Oct-24-17 09:37AM  ETFs with exposure to Enzo Biochem, Inc. : October 24, 2017 Capital Cube
Oct-23-17 08:30AM  Enzo Biochem Announces NYS Department of Healths Approval of a New Womens Health Infectious Disease Panel Business Wire
Oct-21-17 06:16PM  What Investors Should Know About Enzo Biochem Incs (ENZ) Financial Strength Simply Wall St.
Oct-13-17 10:45AM  ETFs with exposure to Enzo Biochem, Inc. : October 13, 2017 Capital Cube
Oct-12-17 02:35PM  Top 5 Biotech Stocks for 2017 Investopedia
Oct-10-17 07:00AM  Earnings Review and Free Research Report: Enzo Biochems Q4 and Annual Top-line Rise on a Y-o-Y Basis ACCESSWIRE
Oct-03-17 10:20PM  Edited Transcript of ENZ earnings conference call or presentation 28-Sep-17 12:30pm GMT Thomson Reuters StreetEvents
Oct-02-17 10:49AM  ETFs with exposure to Enzo Biochem, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:09AM  Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q4, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-28-17 01:48PM  Enzo Biochem Inc (ENZ) Files 10-K for the Fiscal Year Ended on July 31, 2017 GuruFocus.com -6.99%
08:16AM  Enzo Biochem, Inc. breached its 50 day moving average in a Bullish Manner : ENZ-US : September 28, 2017 Capital Cube
06:45AM  Investor Network: Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Sep-27-17 09:16PM  Enzo Biochem posts 4Q profit Associated Press +6.02%
04:16PM  Enzo Biochem posts 4Q profit Associated Press
04:05PM  Enzo Biochem Reports Increase in Revenues and Profitable Fourth Quarter Business Wire
Sep-22-17 03:33PM  Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2017 Results Thursday September 28, 2017 at 8:30 AM E.T. Business Wire
Sep-01-17 09:52AM  Enzo Biochem, Inc. breached its 50 day moving average in a Bullish Manner : ENZ-US : September 1, 2017 Capital Cube
Aug-25-17 06:52PM  Enzo Biochem, Inc. Value Analysis (NYSE:ENZ) : August 25, 2017 Capital Cube
Aug-17-17 09:04AM  Enzo Biochem, Inc. breached its 50 day moving average in a Bearish Manner : ENZ-US : August 17, 2017 Capital Cube
Aug-14-17 10:37AM  Geron's (GERN) Imetelstat Progressing Well, Setbacks Concern Zacks
Aug-12-17 07:00AM  Edited Transcript of ENZ earnings conference call or presentation 9-Jun-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 04:17PM  Catalyst (CPRX) Posts Narrower than Expected Loss in Q2 Zacks
04:14PM  Perrigo (PRGO) Q2 Earnings & Sales Top, 2017 View Raised Zacks
Aug-09-17 02:15PM  Jazz Pharma (JAZZ) Q2 Earnings & Revenues Miss, View Intact Zacks
11:13AM  Orexigen (OREX) Q2 Loss Narrows, Contrave Sales Impress Zacks
11:13AM  Agios (AGIO) Q2 Loss Wider than Expected, Revenues Up Y/Y Zacks
10:53AM  Endocyte (ECYT) Stock Up Despite Wider-than-Expected Q2 Loss Zacks
10:51AM  Achillion (ACHN) Q2 Loss In Line, Gains on Pipeline Update Zacks
Aug-07-17 04:09PM  Epizyme (EPZM) Incurs Narrower-than-Expected Loss in Q2 Zacks
Aug-04-17 04:35PM  Juno Therapeutics (JUNO) Q2 Loss Widens, Revenues Surpass Zacks
10:12AM  Agenus (AGEN) Q2 Loss Narrower Than Expected, Revenues Lag Zacks
08:41AM  AMAG Pharma (AMAG) Incurs Narrower-than-Expected Loss in Q2 Zacks
Aug-02-17 10:24AM  Corcept (CORT) Q2 Earnings Beat Estimates, Guidance Raised Zacks
Aug-01-17 08:30AM  Strongbridge Biopharma (SBBP) Rises: Stock Moves 17% Higher Zacks
Jul-31-17 10:44AM  Dr. Reddy's (RDY) Earnings Decline Y/Y in Q1, Sales Rise Zacks
Jul-28-17 02:33PM  Acorda (ACOR) Q2 Earnings Miss Estimates, Revenues in Line Zacks
09:36AM  Keryx (KERX) Posts Wider than Expected Loss in Q2, Sales Beat Zacks
Jul-27-17 11:27AM  GlaxoSmithKline (GSK) Beats on Q2 Earnings, Lowers Guidance Zacks
11:07AM  Bristol-Myers (BMY) Beats on Q2 Earnings, Tweaks 2017 View Zacks
11:03AM  Alexion (ALXN) Tops Q2 Earnings & Revenues, Ups 2017 View Zacks
Jul-21-17 08:50AM  Galapagos (GLPG) Looks Good: Stock Adds 6.2% in Session Zacks
Jul-20-17 06:19PM  Emergent Inks Agreement to Acquire Anthrax Drug Raxibacumab Zacks
Enzo Biochem, Inc., an integrated diagnostic bioscience company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates in three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment manufactures, develops, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication levels, or search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 30 patient service centers in New York and New Jersey; and a free standing 'STAT' or rapid response laboratory in New York City, as well as a full-service phlebotomy department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HARBERT MANAGEMENT CORP10% OwnerMay 30Buy3.0719,39159,5305,169,337May 30 05:20 PM
HARBERT MANAGEMENT CORP10% OwnerMay 29Buy3.0819,05058,6745,149,946May 30 05:20 PM
HARBERT MANAGEMENT CORP10% OwnerMay 28Buy3.0963,677196,8525,130,896May 30 05:20 PM
HARBERT MANAGEMENT CORP10% OwnerMay 20Buy3.6114,13251,0175,067,219May 22 04:49 PM
BORTZ GREGORY M.DirectorJan 14Option Exercise2.709,18424,79793,699Jan 18 04:30 PM
Perlysky DovDirectorJan 14Option Exercise2.709,18424,79765,787Jan 18 04:30 PM
RABBANI ELAZARChm of the Bd, CEO and SecJan 14Option Exercise2.702,7827,5111,661,003Jan 18 04:31 PM
WEINER BARRY WPres, CFO Prin Acct Ofcr TreasJan 14Option Exercise2.702,2266,0101,136,918Jan 18 04:30 PM
RABBANI ELAZARChm of the Bd, CEO and SecOct 29Buy3.3510,00033,4691,848,668Oct 31 09:06 AM
Perlysky DovDirectorOct 18Buy3.5010,00035,000266,235Oct 22 12:48 PM
Hanna Bruce A.DirectorOct 18Buy3.5215,00052,78737,816Oct 22 09:00 AM